4 transcripts
DOCS
Earnings call transcript
NYSE
2025 Q1
8 Aug 24
for the benefit of health care providers and patients remains unwavering, and we look forward to continuing to innovate in this space.
Okay. Moving
DOCS
Earnings call transcript
NYSE
2024 Q4
16 May 24
market. We believe this outperformance is due to our record engagement industry-leading ROI and continued innovation.
Speaking of innovation, we
DOCS
Earnings call transcript
NYSE
2024 Q3
8 Feb 24
are encouraged by the level of investment our customers are making in Doximity and are excited by the opportunity to continue delivering innovative
DOCS
Earnings call transcript
NYSE
2024 Q1
8 Aug 23
of the specialties that overlap with some of our newest modules are well aligned with some of the excitement and innovation in the life sciences space
- Prev
- 1
- Next